Notably, Klf4 is a major repressor of EMT: its expression prevents EMT and maintains an epithelial morphology of mammary epithelial cells and of breast cancer cells, while its ablation results in a loss of epithelial morphology and in a partial induction and acceleration of EMT. Here, KLF4 is linked to breast carcinoma.